Blood levels of TT virus following immune stimulation with influenza or hepatitis B vaccine

Torque Teno virus (TTV) has been demonstrated to be present persistently in the blood of healthy individuals without evidence that it causes any disease process. The levels of TTV vary in patients co‐infected with other viruses and there has been considerable speculation as to whether TTV contributes to pathogenesis by other viruses or if the varying levels might be related to immune activation in the host. In the present study, the load of TTV was examined in plasma and peripheral blood mononuclear cells (PBMCs) following immunization of subjects with either influenza (a recall antigen) or hepatitis B virus (HBV) (a new antigenic exposure). The results overall did not indicate a significant change in TTV titers over a 90 day observation period; however, when TTV genogroup was taken into consideration there was an increase in viral load in plasma at some time points for subjects persistently infected with genogroup 3. While this was observed in both influenza and HBV immunized subjects, the effect was more profound in HBV vaccination. Thus, it appears that exposure to a new antigen rather than a recall antigen may stimulate TTV replication more effectively. The data further suggest that investigating the interactions between TTV and its host might require to examine specifically each TTV genogroup separately in order to determine if certain TTV types have any role in disease pathogenesis. J. Med. Virol. 75:358–365, 2005. © 2004 Wiley‐Liss, Inc.

[1]  M. Bellini,et al.  Relationship of TT virus and Helicobacter pylori infections in gastric tissues of patients with gastritis , 2003, Journal of medical virology.

[2]  S. Yu,et al.  Effect of Vaccination with Selective Bacterins on Conventional Pigs Infected with Type 2 Porcine Circovirus , 2003, Veterinary pathology.

[3]  A. Boner,et al.  TT Virus Loads and Lymphocyte Subpopulations in Children with Acute Respiratory Diseases , 2003, Journal of Virology.

[4]  M. Degré,et al.  Effect of immune modulation on TT virus (TTV) and TTV‐like‐mini‐virus (TLMV) viremia , 2003, Journal of medical virology.

[5]  G. Antonelli,et al.  Relationships between TT virus infection and hepatitis C virus response to interferon therapy in doubly infected patients. , 2003, Journal of biological regulators and homeostatic agents.

[6]  D. Skiest,et al.  Comparison of the effects of acute influenza infection and Influenza vaccination on HIV viral load and CD4 cell counts. , 2003, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[7]  T. Stadejek,et al.  Reproduction of postweaning multisystemic wasting syndrome (PMWS) in immunostimulated and non-immunostimulated 3-week-old piglets experimentally infected with porcine circovirus type 2 (PCV2) , 2002, Veterinary Microbiology.

[8]  S. Hino TTV, a new human virus with single stranded circular DNA genome , 2002, Reviews in medical virology.

[9]  D. Jayaweera,et al.  Genotypic analysis of plasma HIV-1 RNA after influenza vaccination of patients with previously undetectable viral loads , 2002, AIDS.

[10]  S. Kennedy,et al.  The effects of immuno-modulation on the clinical and pathological expression of postweaning multisystemic wasting syndrome. , 2002, Journal of comparative pathology.

[11]  G. Antonelli,et al.  Dynamics of Persistent TT Virus Infection, as Determined in Patients Treated with Alpha Interferon for Concomitant Hepatitis C Virus Infection , 2001, Journal of Virology.

[12]  M. Pistello,et al.  TT virus (TTV) loads associated with different peripheral blood cell types and evidence for TTV replication in activated mononuclear cells , 2001, Journal of medical virology.

[13]  M. Pistello,et al.  TT virus levels in the plasma of infected individuals with different hepatic and extrahepatic pathology , 2001, Journal of medical virology.

[14]  J. Ellis,et al.  Activation of the Immune System is the Pivotal Event in the Production of Wasting Disease in Pigs Infected with Porcine Circovirus-2 (PCV-2) , 2001, Veterinary pathology.

[15]  M. Pistello,et al.  Molecular Properties, Biology, and Clinical Implications of TT Virus, a Recently Identified Widespread Infectious Agent of Humans , 2001, Clinical Microbiology Reviews.

[16]  H. Ullum,et al.  Prevalence and prognostic significance of infection with TT virus in patients infected with human immunodeficiency virus. , 2000, The Journal of infectious diseases.

[17]  P. Griffiths,et al.  Time to consider the concept of a commensal virus? , 1999, Reviews in medical virology.

[18]  T. Nishizawa,et al.  A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. , 1997, Biochemical and biophysical research communications.

[19]  J. Margolick,et al.  The effect of influenza vaccination on human immunodeficiency virus type 1 load: a randomized, double-blind, placebo-controlled study. , 1996, The Journal of infectious diseases.

[20]  C H Fox,et al.  Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1. , 1996, The New England journal of medicine.

[21]  A. Namazi,et al.  Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination , 1995 .

[22]  Z. Bentwich,et al.  Immune activation is a dominant factor in the pathogenesis of African AIDS. , 1995, Immunology today.

[23]  A. Fauci,et al.  Multifactorial nature of human immunodeficiency virus disease: implications for therapy. , 1993, Science.